Terms: = Bone cancer AND IL7R, P16871, IL-7R-alpha, CDW127, CD127, ENSG00000168685, 3575
50 results:
1. Identification of multiple organ metastasis-associated hub mRNA/miRNA signatures in non-small cell lung cancer.
Zu L; He J; Zhou N; Tang Q; Liang M; Xu S
Cell Death Dis; 2023 Dec; 14(12):798. PubMed ID: 38057344
[TBL] [Abstract] [Full Text] [Related]
2. Single-center phase 2 study of PD-1 inhibitor combined with DNA hypomethylation agent + CAG regimen in patients with relapsed/refractory acute myeloid leukemia.
Gao XN; Su YF; Li MY; Jing Y; Wang J; Xu L; Zhang LL; Wang A; Wang YZ; Zheng X; Li YF; Liu DH
Cancer Immunol Immunother; 2023 Aug; 72(8):2769-2782. PubMed ID: 37166484
[TBL] [Abstract] [Full Text] [Related]
3. The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions.
Dvorak CC; Haddad E; Heimall J; Dunn E; Cowan MJ; Pai SY; Kapoor N; Satter LF; Buckley RH; O'Reilly RJ; Chandra S; Bednarski JJ; Williams O; Rayes A; Moore TB; Ebens CL; Davila Saldana BJ; Petrovic A; Chellapandian D; Cuvelier GDE; Vander Lugt MT; Caywood EH; Chandrakasan S; Eissa H; Goldman FD; Shereck E; Aquino VM; Desantes KB; Madden LM; Miller HK; Yu L; Broglie L; Gillio A; Shah AJ; Knutsen AP; Andolina JP; Joshi AY; Szabolcs P; Kapadia M; Martinez CA; Parrot RE; Sullivan KE; Prockop SE; Abraham RS; Thakar MS; Leiding JW; Kohn DB; Pulsipher MA; Griffith LM; Notarangelo LD; Puck JM
J Allergy Clin Immunol; 2023 Feb; 151(2):547-555.e5. PubMed ID: 36456360
[TBL] [Abstract] [Full Text] [Related]
4. IL-7: Comprehensive review.
Winer H; Rodrigues GOL; Hixon JA; Aiello FB; Hsu TC; Wachter BT; Li W; Durum SK
Cytokine; 2022 Dec; 160():156049. PubMed ID: 36201890
[TBL] [Abstract] [Full Text] [Related]
5. Increased frequency of TIGIT
Brauneck F; Haag F; Woost R; Wildner N; Tolosa E; Rissiek A; Vohwinkel G; Wellbrock J; Bokemeyer C; Schulze Zur Wiesch J; Ackermann C; Fiedler W
Oncoimmunology; 2021 Jun; 10(1):1930391. PubMed ID: 34211801
[TBL] [Abstract] [Full Text] [Related]
6. PRC2 loss of function confers a targetable vulnerability to BET proteins in T-ALL.
Andrieu GP; Kohn M; Simonin M; Smith CL; Cieslak A; Dourthe MÉ; Charbonnier G; Graux C; Huguet F; Lhéritier V; Dombret H; Spicuglia S; Rousselot P; Boissel N; Asnafi V
Blood; 2021 Nov; 138(19):1855-1869. PubMed ID: 34125178
[TBL] [Abstract] [Full Text] [Related]
7. Overexpression of wild-type IL-7Rα promotes T-cell acute lymphoblastic leukemia/lymphoma.
Silva A; Almeida ARM; Cachucho A; Neto JL; Demeyer S; de Matos M; Hogan T; Li Y; Meijerink J; Cools J; Grosso AR; Seddon B; Barata JT
Blood; 2021 Sep; 138(12):1040-1052. PubMed ID: 33970999
[TBL] [Abstract] [Full Text] [Related]
8. Anterior Approach vs Conventional Hepatectomy for Resection of Colorectal Liver Metastasis: A Randomized Clinical Trial.
Rahbari NN; Birgin E; Bork U; Mehrabi A; Reißfelder C; Weitz J
JAMA Surg; 2021 Jan; 156(1):31-40. PubMed ID: 33147332
[TBL] [Abstract] [Full Text] [Related]
9. Retrospective analysis of plasmacytoma in Kansai Myeloma Forum Registry.
Nakaya A; Tanaka H; Yagi H; Ohta K; Shibayama H; Kohara T; Kanda J; Shindo M; Shimura Y; Kosugi S; Kida T; Kaneko H; Imada K; Karasuno T; Matsuda M; Iida M; Adachi Y; Fuchida SI; Uoshima N; Uchiyama H; Takahashi R; Matsui T; Wada K; Kiyota M; Shimazaki C; Hino M; Kuroda J; Kanakura Y; Takaori-Kondo A; Nomura S; Matsumura I;
Int J Hematol; 2020 Nov; 112(5):666-673. PubMed ID: 32783165
[TBL] [Abstract] [Full Text] [Related]
10. Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma.
De Smedt R; Morscio J; Reunes L; Roels J; Bardelli V; Lintermans B; Van Loocke W; Almeida A; Cheung LC; Kotecha RS; Mansour MR; Uyttebroeck A; Vandenberghe P; La Starza R; Mecucci C; Lammens T; Van Roy N; De Moerloose B; Barata JT; Taghon T; Goossens S; Van Vlierberghe P
Blood; 2020 May; 135(19):1685-1695. PubMed ID: 32315407
[TBL] [Abstract] [Full Text] [Related]
11. Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche.
Beneforti L; Dander E; Bresolin S; Bueno C; Acunzo D; Bertagna M; Ford A; Gentner B; Kronnie GT; Vergani P; Menéndez P; Biondi A; D'Amico G; Palmi C; Cazzaniga G
Br J Haematol; 2020 Jul; 190(2):262-273. PubMed ID: 32118299
[TBL] [Abstract] [Full Text] [Related]
12. The TLR9 agonist (GNKG168) induces a unique immune activation pattern in vivo in children with minimal residual disease positive acute leukemia: Results of the TACL T2009-008 phase I study.
Ronsley R; Kariminia A; Ng B; Mostafavi S; Reid G; Subrt P; Hijiya N; Schultz KR
Pediatr Hematol Oncol; 2019 Nov; 36(8):468-481. PubMed ID: 31530240
[No Abstract] [Full Text] [Related]
13. Lineage-negative lymphoma with a helper innate lymphoid cell phenotype.
Li M; Su X; Wang Y; Fan L; Chai J; Li P; Zhao D; Liu Y; Ma J; Wang K; Yan Q; Guo S; Jin B; Liang R; Wang Z
Virchows Arch; 2020 Feb; 476(2):285-293. PubMed ID: 31522287
[TBL] [Abstract] [Full Text] [Related]
14. Stereotactic Ablative Radiation Therapy for Pulmonary Recurrence-Based Oligometastatic Non-Small Cell Lung cancer: Survival and Prognostic Value of Regulatory T Cells.
Liu C; Sun B; Hu X; Zhang Y; Wang Q; Yue J; Yu J
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1055-1064. PubMed ID: 31437470
[TBL] [Abstract] [Full Text] [Related]
15. Yi-qi-yang-yin-tian-sui-fang enhances cisplatin-induced tumor eradication and inhibits interleukin-7 reduction in non-small cell lung cancer.
Ke B; Wu X; Yang Q; Huang Y; Wang F; Gong Y; Liu J; Shi L
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138762
[TBL] [Abstract] [Full Text] [Related]
16. Tumor infiltrating lymphocytes from acute myeloid leukemia marrow can be reverted to CD45RA+ central memory state by reactivation in SIP (Simulated Infective Protocol).
Teo YWB; Linn YC; Goh YT; Li S; Ho LP
Immunobiology; 2019 Jul; 224(4):526-531. PubMed ID: 31072628
[TBL] [Abstract] [Full Text] [Related]
17. High-Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action.
Adams HC; Stevenaert F; Krejcik J; Van der Borght K; Smets T; Bald J; Abraham Y; Ceulemans H; Chiu C; Vanhoof G; Usmani SZ; Plesner T; Lonial S; Nijhof I; Lokhorst HM; Mutis T; van de Donk NWCJ; Sasser AK; Casneuf T
Cytometry A; 2019 Mar; 95(3):279-289. PubMed ID: 30536810
[TBL] [Abstract] [Full Text] [Related]
18. Comparative analysis of immune cell subsets in peripheral blood from patients with periodontal disease and healthy controls.
Cheng WC; Saleh F; Abuaisha Karim B; Hughes FJ; Taams LS
Clin Exp Immunol; 2018 Dec; 194(3):380-390. PubMed ID: 30120837
[TBL] [Abstract] [Full Text] [Related]
19. Co-existence of il7r high and SH2B3 low expression distinguishes a novel high-risk acute lymphoblastic leukemia with Ikaros dysfunction.
Ge Z; Gu Y; Xiao L; Han Q; Li J; Chen B; Yu J; Kawasawa YI; Payne KJ; Dovat S; Song C
Oncotarget; 2016 Jul; 7(29):46014-46027. PubMed ID: 27322554
[TBL] [Abstract] [Full Text] [Related]
20. Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment.
Kordasti S; Costantini B; Seidl T; Perez Abellan P; Martinez Llordella M; McLornan D; Diggins KE; Kulasekararaj A; Benfatto C; Feng X; Smith A; Mian SA; Melchiotti R; de Rinaldis E; Ellis R; Petrov N; Povoleri GA; Chung SS; Thomas NS; Farzaneh F; Irish JM; Heck S; Young NS; Marsh JC; Mufti GJ
Blood; 2016 Sep; 128(9):1193-205. PubMed ID: 27281795
[TBL] [Abstract] [Full Text] [Related]
[Next]
